1-3 of 3
Michael O'Dwyer, MD, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia In Chronic Phase: Updated Results of the ICORG 0802 Phase 2 Study with Analysis of the GeneXpert System Versus IS BCR-ABL RQ PCR.

Eibhlin Conneally, MB, MRCPI, FRCPath, PhD, Ronan T Swords, MD, MRCPI, FRCPath, Francis J. Giles, MB, MD, FRCPI, FRCPath, Mary Frances McMullin, MD, Philipp le Coutre, Stephen Langabeer, Marzena Wieczorkowska, Cliona McDowell, Brian Moulton, Karine Egan, Michael O'Dwyer, MD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 3427.
https://doi.org/10.1182/blood.V116.21.3427.3427
Published: 2010
Journal Articles

The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7/CDK9 Inhibitor, In Acute Myeloid Leukaemia

Ruth C Morrell, MBBCh, FRCPath, Eva Szegezdi, PhD, Anna Halpin-McCormick, BSc, Karen Cawley, BSc, Afshin Samali, PhD, Michael O'Dwyer, MD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 1841.
https://doi.org/10.1182/blood.V116.21.1841.1841
Published: 2010
Journal Articles

G2/M Arrest Sensitizes Chronic Myelogenous Leukemia Cells to TRAIL-Induced Apoptosis

David Devlin, Medical, Student, Eva Szegezdi, Post-Doctoral, Researcher, Paavilainen Tanja, Student, Orsolya Orosz, Student, Michael O'Dwyer, MD, FRCPath, Michael Carty, Senior, Lecturer, Afshin Samali, PhD, SeĢverine Cruet Hennequart, PhD
Journal: Blood
Blood (2010) 116 (21): 4465.
https://doi.org/10.1182/blood.V116.21.4465.4465
Published: 2010